pSivida boosts US focus

Perth-based nanotechnology company pSivida Limited has appointed two new non-executive directors, both based in the United States. David Mazzo is currently president and chief executive officer of Chugai Pharma USA, while Michael Rogers is executive vice-president and chief financial officer of Indevus Pharmaceuticals Incorporated.The two appointments reflect the increased visibility of pSivida in the US market, following their NASDAQ listing earlier this year. The company has also become a founding member of NASDAQ’s new health care index.

Add your comment

BNIQ sponsored byECU School of Business and Law


6th-Australian Institute of Management WA20,000
7th-Murdoch University16,584
8th-South Regional TAFE10,549
9th-Central Regional TAFE10,000
10th-The University of Notre Dame Australia6,708
48 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer